CENTER FOR DISEASE CONTROL (CDC)
November 4, 2022
The Centers for Disease Control recommends LLLT/PBM in their Updated Clinical Practice Guideline for Pain Care and Opioid Use.
Noninvasive Nonpharmacologic Approaches to Subacute and Chronic Pain
April 11, 2022
Scot Faulkner submitted comments endorsing PBM use as part of CDC’s new opioid prescription and pain management guidelines under “Noninvasive Nonpharmacological treatments for chronic pain.”
July 22, 2021
CDC Opioid Policy Guidelines – Final Report
Scot Faulkner submitted expanded written remarks and research documents on PBM.
July 16, 2021
Board Meeting of Scientific Counselors – Opioid Prescription Guidelines
Scot Faulkner participated and presented testimony on PBM as a viable pain management alternative.
February 16, 2021
Board Meeting of Scientific Counselors – Opioid Prescription Guidelines
Scot Faulkner participated and presented testimony on PBM as a viable pain management alternative.
July 22, 2020
Board Meeting of Scientific Counselors – Opioid Prescription Guidelines
Scot Faulkner participated and presented testimony on PBM as an opioid alternative.
CENTER FOR MEDICARE/MEDICAID SERVICES (CMS)
August 24, 2023
Research America – Advocacy Network discussion with CMS
Scot Faulkner provided commentary regarding PBM National Coverage Determination.
May 23 ,2023
Scot Faulkner meetings with CMS officials regarding National Coverage Determination.
December 14, 2022
Scot Faulkner met with CMS leaders on PBM coverage determinations.
March 29, 2022
Scot Faulkner briefed CMS leaders at the Center for Clinical Standards and Quality on initiating a National Coverage Determination (NCD) for reimbursing PBM pain management treatments.
February 9, 2022
Scot Faulkner met with CMS leaders on their supporting and including PBM clinical trials that include, but are not just limited to, seniors in their coverage determinations.
December 15, 2021
Scot Faulkner participated in a Research America discussion with CMS Chief Medical Officer on evidence development for National Coverage Determinations.
November 1, 2021
Scot Faulkner met with CMS leaders to discuss PBM reimbursement for pain management.
October 25, 2021
Scot Faulkner met with CMS leaders to discuss PBM reimbursement for pain management.
September 10, 2021
Scot Faulkner submitted comments in support of separate coding and payment for provider activities involved in chronic pain management.
September 20, 2019
National Opioid Task Force – Strategic Planning Meeting
Scot Faulkner participated and presented testimony on PBM as an opioid alternative.
CONGRESS
September 7, 2023
Scot Faulkner meets with Senator Manchin’s staff to review PBM/VA funding status.
September 4, 2023
Scot Faulkner reviews PBM/VA funding language with Appropriation staff.
August 28, 2023
Scot Faulkner meets with Rep. Alex Mooney staff to explore PBM/VA funding options.
August 21, 2023
Scot Faulkner continues discussions on PBM/VA funding options Senator Manchin’s staff.
August 18, 2023
Scot Faulkner continues discussions on PBM/VA funding options Senator Manchin’s staff.
August 11, 2023
Scot Faulkner discusses PBM/VA funding options (CR/Omnibus/Supplemental) with Senator Manchin’s Appropriations staff.
August 1, 2023
Scot Faulkner discusses PBM/VA funding options (CR/Omnibus/Supplemental) with Rep. Rosendale and other Members.
July 24-26, 2023
Scot Faulkner follows-up with Congressional colleagues regarding VA Appropriations.
July 12, 2023
Scot Faulkner follows-up with House Appropriation Members regarding VA/PBM funding.
June 15, 2023
Scot Faulkner follows-up with Congressional colleagues regarding VA Appropriations.
May 4, 2023
Scot Faulkner briefs Congressional colleagues on PBM healing Pope Francis.
May 1-4, 2023
Scot Faulkner meets with staff for Senators Hassan, King, and Warren on expanding PBM availability for veterans.
April 26, 2023
Scot Faulkner meets with staff for Senators Blumenthal and Brown on expanding PBM availability for veterans.
April 11, 2023
Scot Faulkner meets with staff for Senator Lee on expanding PBM availability for veterans.
April 10, 2023
Scot Faulkner meets with House Committee on Veterans Affairs regarding expanding PBM availability for veterans.
March 16, 2023
Scot Faulkner meets with Senate Veterans Affairs Committee on expanding PBM availability for veterans.
March 13, 2023
Scot Faulkner meets with staff for Senators Capito, Romney, and Tester on expanding PBM availability for veterans.
Scot Faulkner meets with Utah Congressional Delegation staff on expanding PBM availability for veterans.
March 10, 2023
Scot Faulkner meets with Senator Manchin staff on expanding PBM availability for veterans.
January 31, 2023
Scot Faulkner meets with Congressman Rosendale’s staff on expanding PBM availability for veterans.
October 27, 2022
Scot Faulkner met with Congressional colleagues promoting PBM reimbursement.
October 13, 2022
Scot Faulkner briefed Congressional colleagues on PBM treating Parkinson’s.
March 8, 2022
Scot Faulkner met with Congressional leaders on promoting PBM reimbursement.
September 18. 2022
Scot Faulkner briefed Congressional colleagues on PBM advances relating to Long-COVID.
September 15. 2022
Scot Faulkner briefed Congressional colleagues on PBM advances relating to Long-COVID.
August 1, 2022
Scot Faulkner briefed Congressional colleagues on PBM treating veterans’ neurological conditions.
May 12, 2022
Scot Faulkner briefed Congressional colleagues on PBM treating veterans’ neurological conditions.
April 29, 2022
Scot Faulkner met with Congressional leaders on promoting PBM research funding.
March 8, 2022
Scot Faulkner met with Congressional leaders on promoting PBM research and supporting ARPA-H.
November 4, 2021
Scot Faulkner met with Congressional leaders regarding PBM preventing cancer therapy side-effects.
October 7, 2021
Scot Faulkner met with Rep. Jim Hagedorn (R-MN) and drug rehabilitation organizations on the use of PBM to treat Opioid Use Disorder (OUD).
October 3, 2021
Rep. Alex Mooney (R-WV) addressed PBM2021, arranged by Scot Faulkner.
October 2, 2021
Rep. Jim Hagedorn (R-MN) addressed PBM2021, arranged by Scot Faulkner
JULY 8, 2021
Research America – Advocacy Network Drafting Session on CURES 2.0 Legislation
Scot Faulkner submitted ideas and questions on funding innovative technology.
JUNE 10, 2021
Research America – Advocacy Network Strategy Meeting on Congressional Legislation
Scot Faulkner co-facilitated session and reported on discussions.
JULY 24, 2020
Scot Faulkner worked with Research America on successfully reinstating research funding for NIH and BARDA in Fiscal 2021 Appropriations Legislation.
JUNE 9, 2020
Pain Management Congressional Awareness Day
Scot Faulkner participated with U.S. Pain Foundation in promoting PBM as an important pain treatment and recommended Medicare reimbursement.
APRIL 2, 2019
Science Education Congressional Outreach Day
Scot Faulkner keynoted event
Dr. Kelly Huffer (Shepherd University) demonstrated PBM pain management treatments
OCTOBER 11, 2018
Congressional Briefing on PBM’s Role in reducing Opioid Use
James Carroll, Praveen Arany, and Annette Quinn (UPMC) presented testimony on PBM’s efficacy in pain management to Congressional staff and the media.
DEPARTMENT OF DEFENSE
February 3, 2023
Ann Liebert and Scot Faulkner brief Fort Detrick Research Leadership on PBM and explore collaboration.
February 24, 2022
Scot Faulkner and Dr. Bob Bowen briefed leaders of TRICARE on use of PBM in military hospitals and providing PBM services to active-duty military and their dependents.
August 27, 2021
Scot Faulkner briefs senior policy officials on PBM’s potential for treating respiratory conditions arising from COVID-19 and biological/chemical warfare.
August 31, 2021
Scot Faulkner and Dr. Bob Bowen brief senior Defense Production Act officials on PBM COVID-19 clinical trial and production scaling.
DEPARTMENT OF VETERANS AFFAIRS
August 24, 2023
Scot Faulkner discusses funding requirements with Salt Lake City VA.
August 24, 2023
Scot Faulkner follows-up with Martinsburg VA Neurology Team.
August 9, 2023
Dr. Bowen and Scot Faulkner brief and demonstrate PBM devices to Martinsburg VA.
August 4, 2023
Scot Faulkner calls VA procurement officials and contractors on year-end funding for PBM.
July 31, 2023
Scot Faulkner emails 700 VA neurologists explaining year-end funding for PBM.
June 27, 2023
Scot Faulkner coordinates with Boston VA on funding PBM treatments for veterans.
June 21, 2023
Scot Faulkner coordinates with Boston VA on promoting PBM treatments for veterans.
June 5, 2023
Scot Faulkner meets with VA Policy team promoting PBM treatments for veterans. Obtains documentation of formal recommendation of PBM by VA’s National Center for Compassionate Care Innovation.
March 30, 2023
Scot Faulkner coordinates with Salt Lake City VA on promoting PBM treatments for veterans.
March 6, 2023
Scot Faulkner submits letter to VA Secretary promoting PBM treatments for veterans.
March 1, 2023
Scot Faulkner meets with Neurologists at Salt Lake City VA to discuss PBM treating TBI, CTE, and PTSD.
February 17, 2023
Scot Faulkner meets with Neurologists at Boston VA to discuss PBM treating TBI, CTE, and PTSD.
March 23, 2022
James Carroll and Scot Faulkner brief VA leaders on conducting PBM clinical trials.
August 16, 2021
Scot Faulkner meets with VA leaders on using PBM for pain management and supporting physical rehabilitation.
January 30, 2020
James Carroll conducts “Grand Round” PBM training for physicians and specialists at the Martinsburg Veterans Medical Center.
DEPARTMENT OF HOMELAND SECURITY (DHS)
May 24, 2023
Scot Faulkner meets with DHS National Emergency Training Center team to discuss PBM treatments for First Responders.
April 28, 2020
James Carroll, Praveen Arany, Bob Bowen, and Scot Faulkner briefed leaders of the Science & Technology Directorate on the potential of PBM treating respiratory conditions arising from COVID-19.
EXECUTIVE OFFICE OF THE PRESIDENT
October 1, 2021
Dr. Tara Schwetz, Health Advisor to President Biden addressed PBM2021, arranged by Scot Faulkner
September 10, 2021
Scot Faulkner and James Carroll brief the Assistant Director for Biomedical Science Initiatives in the White House Office of Science and Technology Policy (OSTP) on PBM as a breakthrough nonpharmacological therapy that should be a priority for the ARPA-H initiative.
August 2, 2021
White House Office of Science & Technology Policy (OSTP)
Listening Session on establishing the Advanced Research & Project Agency for Health (ARPA-H)
Scot Faulkner submitted questions and comments considering PBM as a priority “breakthrough technology”
8/2 Listening Session with White House OSTP – Q&A participation
July 23, 2021
White House Office of Science & Technology Policy (OSTP)
Listening Session on establishing the Advanced Research & Project Agency for Health (ARPA-H)
Scot Faulkner submitted questions relating to PBM being considered as a “transformative delivery system”.
July 14, 2021
White House Office of Science & Technology Policy (OSTP)
Discussion on establishing the Advanced Research & Project Agency for Health (ARPA-H)
Scot Faulkner submitted questions relating to ARPA-H’s potential for supporting PBM research.
March 23, 2020
Scot Faulkner briefed members of the COVID-19 Task Force on the potential of PBM treating respiratory conditions arising from the disease.
April 9, 2019
James Carroll and Scot Faulkner briefed Domestic Policy Staff on PBM’s efficacy in pain management and its role in reducing opioid use.
October 11, 2018
James Carroll, Praveen Arany, Annette Quinn (UPMC) and Scot Faulkner briefed leaders of the Office of National Drug Control Policy (ONDCP) on PBM’s efficacy in pain management and its role in reducing opioid use.
FOOD AND DRUG ADMINISTRATION (FDA)
July 13, 2023
Scot Faulkner discusses implementing FDA new PBM Clearance process with policy officials.
February 15, 2023
Scot Faulkner discusses FDA new PBM Clearance process with Commissioner.
January 11, 2023
Scot Faulkner submits written comments in support of FDA’s new PBM Clearance process.
November 2022
Scot Faulkner coordinated congressional and public support for PBM Covid-19 Submissions.
September 21, 2022
Scot Faulkner briefed FDA officials on PBM Covid-19 Submission
December 13, 2019
James Carroll and Scot Faulkner presented testimony on revising PBM’s regulatory environment and establishing PBM as a separate Code.
HEALTH & HUMAN SERVICES (HHS)
May 1, 2020
James Carroll, Praveen Arany, Bob Bowen, and Scot Faulkner briefed leaders of the Biomedical Advanced Research and Development Authority (BARDA) on the potential of PBM treating respiratory conditions arising from COVID-19.
October 29, 2019
James Carroll and Scot Faulkner briefed Policy Advisors to Assistant Secretary for Health on PBM’s efficacy in pain management and its role in reducing opioid use.
July 2, 2019
Scot Faulkner briefed Policy Advisors to Assistant Secretary for Health on PBM’s efficacy in pain management and its role in reducing opioid use.
May 9, 2019
Pain Management Best Practices Interagency Meeting
Scot Faulkner participated and presented testimony on PBM as an opioid alternative.
NATIONAL INSTITUTES OF HEALTH
September 20, 2023
Scot Faulkner briefs Acting Director of NIH Medical Library on PBM publications.
September 1, 2023
Scot Faulkner participates in U.S. Pain Foundation discussion with Director of HEAL program [Healing End Addiction Long-term].
January 10, 2023
Praveen Arany organized forum on PBM held by the National Institute on Aging.
January 25, 2022
Scot Faulkner participated in Research America discussion with NIH Extramural Research leaders on partnerships and funding.
September 13, 2021
Scot Faulkner participated in Research America strategic dialogue with NIH leaders on ARPA-H legislation.
May 27, 2021
Scot Faulkner discussed SEED Grant Program opportunities for PBM start-ups.
May 6, 2021
Research America – Advocacy Network discussion with National Cancer Institute
Scot Faulkner submitted questions and comments regarding funding PBM research and RCTs on Oral Mucositis.
July 13, 2020
The National Center for Complementary and Integrative Health (NCCIH) – Strategic Planning for Research
Scot Faulkner submitted report on expanding research on PBM’s efficacy in pain management.
U.S. DEPARTMENT OF AGRICULTURE
February 2, 2023
Don Patthoff, Ann Liebert, and Scot Faulkner brief USDA Research Leadership on PBM and explore collaboration.
January 10, 2023
Praveen Arany organized forum on PBM held by the National Institute on Aging.
January 25, 2022
Scot Faulkner participated in Research America discussion with NIH Extramural Research leaders on partnerships and funding.
September 13, 2021
Scot Faulkner participated in Research America strategic dialogue with NIH leaders on ARPA-H legislation.
May 27, 2021
Scot Faulkner discussed SEED Grant Program opportunities for PBM start-ups.
May 6, 2021
Research America – Advocacy Network discussion with National Cancer Institute
Scot Faulkner submitted questions and comments regarding funding PBM research and RCTs on Oral Mucositis.
July 13, 2020
The National Center for Complementary and Integrative Health (NCCIH) – Strategic Planning for Research
Scot Faulkner submitted report on expanding research on PBM’s efficacy in pain management.